Ascentawits

About:

Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.

Website: https://www.ascentawits.com

Top Investors: CICC, Cowin Capital, Shenzhen Guozhong Venture Capital Management, Sangel Capital, BGI Co-Win

Description:

Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs. The company utilizes specific tumor micro-environments to carry out independent innovative drug designs and screening for the development of new anti-tumor drugs.

Total Funding Amount:

200M CNY

Headquarters Location:

Shenzhen, Guangdong, China

Founded Date:

2017-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2021-02-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai